I think there is this divergence among longs some of whom think the FDA should be driving CYDY’s EUA. This line of thought seems unlikely to me along the same lines that OWS typically does not knock on your door with a check to hand you because they heard you were doing good stuff. These things have to go through appropriate channels, a process in which we currently are. I said it earlier that the most I can be upset with the FDA about is if they are, in their talks with CYDY, effectively suggesting an EUA is out of the question at this point. That to me is more fruitfully debatable, not whether the FDA will approve an application for something not applied for yet.
Market Data 
Markets 
AI
